EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Dupilumab Combined with Glucocorticoids in the Treatment of Pemphigus Vegetans: Case Report

Heng Wang, Wenkang Cheng, Shukang Li, Jiyun Tang, Biao Yu, Hualiang Nan, Changpei Lu, Han Zhang, Xueting Zhang, Ting Luo, Xuefei Ke, Haixia Jing

Case Reports in Dermatology · 02.05.2026 · 18 (1) · 278-283

DOI: 10.1159/000551428 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Dermatology, online erschienen am 02.05.2026. Verfasst von Heng Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Taihe Hospital, Hubei University of Medicine, Hubei, China. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Vegetative lesions arise from various causes, with typical examples including pemphigus vegetans and pyoderma vegetans (PDV). Differential diagnosis, treatment selection, and long-term management remain challenging. Systemic glucocorticoids are the conventional first-line therapy for pemphigus diseases, often combined with nonspecific immunosuppressants such as cyclosporine. Dupilumab, a monoclonal antibody targeting IL-4Rα, has recently been reported as a potential therapeutic option for pemphigus vegetans. Case Presentation: We report a 74-year-old woman presenting with painful perianal nodules, plaques, and ulcers for more than 3 months, accompanied by oral ulcers and weight loss. Skin biopsy demonstrated pseudoepitheliomatous hyperplasia with partial epidermal erosion. Laboratory testing revealed positive pemphigus antibodies, and skin secretion culture isolated Proteus mirabilis. Ambulatory electrocardiography indicated third-degree atrioventricular block. Positron emission tomography-computed tomography showed no evidence of malignancy. The patient was treated with dupilumab combined with systemic glucocorticoids and doxycycline, resulting in progressive shrinkage and eventual healing of the lesions.

Conclusion

In cases of vegetative lesions with pseudoepitheliomatous hyperplasia and positive Dsg3 antibodies, pemphigus vegetans should be considered, while PDV and paraneoplastic syndrome must be excluded. For patients with severe comorbidities, dupilumab combined with low-dose glucocorticoids may represent a therapeutic option after careful evaluation of immunosuppressive risks. To our knowledge, this is the first reported case of pemphigus vegetans successfully treated with dupilumab.

Schlagwörter

Stichwörter der Autor:innen

Corticosteroid therapyDupilumabPemphigus vegetansProteus mirabilisPyoderma vegetans

Autor:innen und Institutionen

  • Department of Dermatology, Taihe Hospital, Hubei University of Medicine, Hubei, China.
  • Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Shiyan, Hubei, China.

Zitieren

APA

Wang, H., Cheng, W., Li, S., Tang, J., Yu, B., Nan, H., Lu, C., Zhang, H., Zhang, X., Luo, T., Ke, X., & Jing, H. (2026). Dupilumab Combined with Glucocorticoids in the Treatment of Pemphigus Vegetans: Case Report. Case Reports in Dermatology, 18(1), 278-283. https://doi.org/10.1159/000551428

Vancouver

Wang H, Cheng W, Li S, Tang J, Yu B, Nan H, et al. Dupilumab Combined with Glucocorticoids in the Treatment of Pemphigus Vegetans: Case Report. Case Reports in Dermatology. 2026;18(1):278-283. doi:10.1159/000551428

BibTeX
@article{Wang2026,
  author = {Wang, Heng and Cheng, Wenkang and Li, Shukang and Tang, Jiyun and Yu, Biao and Nan, Hualiang and Lu, Changpei and Zhang, Han and Zhang, Xueting and Luo, Ting and Ke, Xuefei and Jing, Haixia},
  title = {Dupilumab Combined with Glucocorticoids in the Treatment of Pemphigus Vegetans: Case Report},
  journal = {Case Reports in Dermatology},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {278--283},
  doi = {10.1159/000551428}
}
Kostenlos starten →